Literature DB >> 29949488

Progress in Nonmetastatic Prostate Cancer.

Matthew R Smith1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29949488     DOI： 10.1056/NEJMe1805733

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

Review 1.  Management of Nonmetastatic Castration-Resistant Prostate Cancer: Recent Advances and Future Direction.

Authors:  John Esther; Benjamin L Maughan; Neysi Anderson; Neeraj Agarwal; Andrew W Hahn
Journal:  Curr Treat Options Oncol       Date:  2019-02-11

Review 2.  Precision Targets for Intercepting the Lethal Progression of Prostate Cancer: Potential Avenues for Personalized Therapy.

Authors:  Max Christenson; Chung-Seog Song; Ya-Guang Liu; Bandana Chatterjee
Journal:  Cancers (Basel)       Date:  2022-02-11       Impact factor: 6.639

Review 3.  Apalutamide, Darolutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC): A Critical Review.

Authors:  Carlo Cattrini; Orazio Caffo; Ugo De Giorgi; Alessia Mennitto; Alessandra Gennari; David Olmos; Elena Castro
Journal:  Cancers (Basel)       Date:  2022-03-31       Impact factor: 6.639

4.  Nonmetastatic castration-resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy.

Authors:  Soichiro Yoshida; Yoh Matsuoka; Kazuma Toda; Sho Uehara; Hajime Tanaka; Minato Yokoyama; Kazutaka Saito; Ryoichi Yoshimura; Yasuhisa Fujii
Journal:  IJU Case Rep       Date:  2021-05-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.